MetaHealth R1

SingtelMBeCW260730

Geely MB ePW261005

Abundance

Autagco

HSI 28000MBePW260629

Teho

Alibaba MB eCW260703

Acesian Partners

NKY 55000MBePW260911

NKY 52000MBePW260612

9XDR

VZ2R

Meta Health Limited and 5Digital Pte. Ltd. have reached a settlement of $136,831.82 with former executives Vasanthan Metupalle and Jagannathan Padmaja Sakthi, related to ongoing bankruptcy proceedings. The payment will be made in nine tranches starting from September. This settlement follows a disputed $200,000 payable owed by 5Digital to the executives. Upon receiving the first payment, 5Digital will discontinue its bankruptcy claim against them, with no costs ordered.

Singapore Business Review

Meta Health

MetaHealth R

Meta Health, 5Digital reach $136.8k settlement with former executives

Meta Health Limited has extended the deadline for its potential acquisition of 30% of Aios Bio Sciences Pte. Ltd. from February 2, 2025, to May 3, 2025. This extension, agreed upon with vendor Mr. Davin Ng, allows more time for due diligence and negotiations, reflecting the company's strategic interest in the acquisition, which could significantly impact its operations and market positioning. Meta Health Limited is based in Singapore and focuses on expanding its market presence through strategic acquisitions.

- Meta Health Limited has announced an update on its negotiations to acquire 30% of Aios Bio Sciences Pte. Ltd.  
- The initial term sheet expired on February 2, 2025, but the deadline has been extended to May 3, 2025, for further due diligence and negotiations.  
- This acquisition could significantly impact Meta Health's operations and market positioning as it seeks to expand its presence in the healthcare industry.  

Tip Ranks

Meta Platforms

Meta Health Limited Extends Deadline for Potential Acquisition of Aios Bio Sciences

Meta Health Limited has raised approximately S$1.43 million from a rights issue, with S$882,000 already utilized for repaying loans and supporting working capital. This move aims to enhance the company's financial stability and operational capabilities, potentially boosting its market position and stakeholder confidence. The company, incorporated in Singapore, operates in the healthcare sector, focusing on health-related services and products. Current market cap stands at S$7.92 million, with a consensus rating of 'Buy' for its stock.

- Meta Health Limited has raised approximately S$1.43 million from a rights issue, which will be used for repaying loans and supporting working capital.  
- The company has already utilized S$882,000 of the funds, aiming to enhance its operational capabilities and financial stability.  
- Meta Health Limited operates in the healthcare industry in Singapore, focusing on health-related services and products.

Meta Health Limited Utilizes Proceeds from Rights Issue to Strengthen Financial Position

Meta Health Limited has successfully completed its rights issue, which was oversubscribed with 267,789,484 shares accepted, surpassing the 264,078,029 shares available. This reflects strong shareholder confidence and may enhance the company's financial position. The current market cap stands at S$7.92M, with a consensus rating of 'Buy' for the stock.

- TipRanks' Smart Score is a data-driven tool designed to help investors identify top-performing stocks and make informed decisions.  
- Meta Health Limited has successfully completed an oversubscribed rights issue, receiving applications for 267,789,484 shares, surpassing the 264,078,029 shares available, indicating strong shareholder confidence.  
- This development may enhance the company's financial position and positively impact its operations, with a current market cap of S$7.92M.

MetaHealth R1(VZ2R.SG)

Meta Health, 5Digital reach $136.8k settlement with former executives

Meta Health Limited Extends Deadline for Potential Acquisition of Aios Bio Sciences

Meta Health Limited Utilizes Proceeds from Rights Issue to Strengthen Financial Position

Meta Health Limited’s Successful Rights Issue Oversubscribed